Compare VVOS & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VVOS | EQS |
|---|---|---|
| Founded | 2016 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7M | 18.9M |
| IPO Year | 2020 | N/A |
| Metric | VVOS | EQS |
|---|---|---|
| Price | $1.82 | $1.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.25 | N/A |
| AVG Volume (30 Days) | ★ 149.2K | 9.3K |
| Earning Date | 11-19-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $17,317,000.00 | $1,377,000.00 |
| Revenue This Year | $28.86 | N/A |
| Revenue Next Year | $48.70 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 18.76 | ★ 21.11 |
| 52 Week Low | $1.67 | $0.74 |
| 52 Week High | $7.95 | $2.49 |
| Indicator | VVOS | EQS |
|---|---|---|
| Relative Strength Index (RSI) | 37.92 | 36.93 |
| Support Level | $1.67 | $1.30 |
| Resistance Level | $1.83 | $1.42 |
| Average True Range (ATR) | 0.16 | 0.06 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 16.39 | 41.33 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.